0.00
100.00%
-13.60
시간 외 거래:
13.26
13.26
+
Pieris Pharmaceuticals Inc (PIRS) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
95.92%
0.053
|
1.299 | 19.52 | 20.05 | 1.936 |
Operating Expenses
|
7.66%
5.356
|
5.80 | 31.33 | 17.99 | 17.45 |
Benefits Costs and Expenses |
100.00%
-
|
67.35 | - | - | - |
Costs And Expenses |
810.88%
5.356
|
0.588 | 31.33 | 17.99 | 17.45 |
Operating Income/Loss |
17.82%
-5.303
|
-4.501 | -11.81 | 2.063 | -15.51 |
Income/Loss From Continuing Operations Before Tax |
100.08%
0.053
|
-66.06 | 19.52 | 20.05 | 1.936 |
Income/Loss From Continuing Operations After Tax |
6.70%
-4.892
|
-4.585 | -10.75 | 3.976 | -13.18 |
Net Income/Loss
|
6.72%
-4.892
|
-4.584 | -10.75 | 3.976 | -13.18 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
58.36%
1.237
|
2.971 | 98.85 | 87.64 | 74.52 |
Basic Earnings Per Share |
9,775%
-3.95
|
-0.04 | -0.11 | 0.05 | -0.18 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):